GDF15 and Alzheimer disease: The suppression of ISR activation alleviates AD symptoms (Ma et al., 2013; Hwang et al., 2017), therefore, we cannot totally exclude the possibility, though unlikely, that the chronic expression of GDF15 may play a role in the pathogenesis of AD and thus GDF15 could be considered as a potential target to treat AD.